The global cancer diagnostics market was valued at $121.3 Bn in 2023 and is projected to reach approximately $189.5 Bn by 2030, growing at a CAGR of 6.8% from 2024 - 2030. This growth is primarily driven by the rising glob... Read More
The global immunoassay market will witness a robust CAGR of 7.3%, valued at $24.30 billion in 2021, expected to appreci... Read More
The global lateral flow assays market will witness a robust CAGR of 4.34%, valued at $8.76 billion in 2021, expected t... Read More
The global colonoscopy devices market will witness a robust CAGR of 5.1%, valued at $1.37 billion... Read More